It is encouraging to see the level of current investment and its breadth. With the continuing rise of antimicrobial resistance and implications cutting across all areas of medicine, investments are a necessary foundation for urgently needed progress. The Dynamic Dashboard will help funders in their future funding decisions. Some high-level summary of information from the Dynamic Dashboard can be found here.
26.06.2026
Brussels Discussions Advance Europe’s Antibiotic Innovation Agenda
The Global AMR R&D Hub contributed to two high-level discussions in Brussels on strengthening Europe’s antibiotic innovation ecosystem, with Deputy Director Dr. Ralf Sudbrak and Suzanne Edwards sharing evidence and expertise on investment, pull incentives, and the future of antibiotic R&D.
